1. Up Front

   Up Front 22 January 2024 Pages: 405 - 406

   

2. Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research

   • Jeremy Basset-Sagarminaga
   • Tineke van de Weijer
   • Vera Schrauwen-Hinderling

   Review 15 December 2023 Pages: 407 - 419

   

3. The impact of taxing sugar-sweetened beverages on diabetes: a critical review

   • José L. Peñalvo

   Review 04 January 2024 Pages: 420 - 429

   

4. Type 2 diabetes and succinate: unmasking an age-old molecule

   • Sonia Fernández-Veledo
   • Anna Marsal-Beltran
   • Joan Vendrell

   Review Open access 05 January 2024 Pages: 430 - 442

   

5. Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review

   • Rabeeyah Ahmed
   • Russell J. de Souza
   • Sonia S. Anand

   Article Open access 04 January 2024 Pages: 443 - 458

   

6. Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study

   • Edward W. Gregg
   • Haiying Chen
   • for the Look AHEAD Research Group

   Article Open access 18 January 2024 Pages: 459 - 469

   

7. Dose–response effects on HbA_1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial

   • Matthias Blüher
   • Julio Rosenstock
   • Anita M. Hennige

   Article Open access 14 December 2023 Pages: 470 - 482

   

8. Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study

   • Arunkumar Krishnan
   • Carolin V. Schneider
   • Saleh A. Alqahtani

   Article Open access 20 December 2023 Pages: 483 - 493

   

9. Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study

   • Peter J. Raubenheimer
   • Joanna Skelton
   • Naomi S. Levitt

   Article Open access 19 January 2024 Pages: 494 - 505

   

10. MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial

    • Yoriko Heianza
    • Tao Zhou
    • Lu Qi

    Article 05 December 2023 Pages: 506 - 515

    

11. Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018

    • Nolwenn Regnault
    • Elodie Lebreton
    • Emmanuel Cosson

    Article Open access 05 January 2024 Pages: 516 - 527

    

12. GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion

    • Nikhil R. Gandasi
    • Rui Gao
    • Patrik Rorsman

    Extended Article Open access 21 December 2023 Pages: 528 - 546

    

13. NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function

    • Sharon Baumel-Alterzon
    • Liora S. Katz
    • Donald K. Scott

    Article 11 January 2024 Pages: 547 - 560

    

14. Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy

    • Roshan Dhanapalaratnam
    • Tushar Issar
    • Arun V. Krishnan

    Short Communication 08 January 2024 Pages: 561 - 566

    

15. Comments on the notion of false positivity in measurements of autoantibodies

    • Valdemar Grill
    • Elin Sørgjerd
    • Sofia Carlsson

    Letter 04 January 2024 Pages: 567 - 568

16. Comments on the notion of false positivity in measurements of autoantibodies. Reply to Grill V, Sørgjerd E, Hals I, Carlsson S [letter]

    • Nicholas J. Thomas
    • Angus G. Jones

    Letter 04 January 2024 Pages: 569 - 570